Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Hengrui Set For Biggest Biopharma IPO So Far This Year
Hong Kong Listing To Raise Up To $1.27bn
May 15 2025
•
By
Dexter Jie Yan
Hengrui to gross up to $1.27bn from initial public offering in Hong Kong SAR • Source: Shutterstock: stavklem
More from China
More from Financing